Pfizer

Pfizer Stock (PFE) News Today: 2026 Guidance, Analyst Forecasts, Dividend Outlook, and Pipeline Catalysts (Updated Dec. 21, 2025)

Pfizer Inc. (NYSE: PFE) is heading into 2026 with a familiar mix of strengths and stress fractures: a fortress-scale commercial footprint and one of Big Pharma’s deepest development machines—paired with fading COVID-era revenue, looming loss-of-exclusivity headwinds, and heightened political pressure

21 December 2025

Pfizer Stock (PFE) in Focus: 2026 Guidance, Drug-Price Deal Pressures, and Pipeline Catalysts Investors Are Watching

Dec. 21, 2025 — Pfizer Inc. (NYSE: PFE) ends the week in the spotlight after management laid out a 2026 outlook that undershot some Wall Street expectations, while a string of pipeline updates, partnerships, and policy headlines reshaped the near-term

21 December 2025

Drug Pricing · Investment Strategies · Market Analysis · NYSE:PFE · Pharmaceutical Industry · Stock Market

Pfizer Stock (NYSE: PFE) on Dec. 20, 2025: 2026 Forecast, Dividend Outlook, and the Catalysts Wall Street Is Watching

Pfizer’s stock is ending 2025 in a familiar place: caught between near-term headwinds (shrinking COVID-era revenue, a growing patent cliff, and U.S. drug-pricing pressure) and a late-decade recovery narrative built around oncology, obesity, and pipeline execution. As of the latest

21 December 2025

Dividends · Financial Forecasts · Investing · NYSE:PFE · Pfizer · Stock Market

Pfizer Stock (PFE) News Today: 2026 Guidance, TrumpRx Drug-Pricing Deals, Dividend, and Analyst Forecasts (Dec. 20, 2025)

Pfizer Inc. stock (NYSE: PFE) is ending the week in a familiar place: the mid-$20s. But the story behind that “quiet” price is anything but quiet. Investors are weighing Pfizer’s newly issued 2026 outlook, an evolving U.S. drug-pricing landscape tied

20 December 2025

Analyst Forecasts · Dividend Investing · Drug Pricing · NYSE:PFE · Pharmaceuticals · Stock Market

Pfizer Stock (PFE) News Today: 2026 Guidance, Analyst Price Targets, Dividend Outlook and Key Catalysts on Dec. 19, 2025

Pfizer Inc. (NYSE: PFE) is ending the week with investors weighing a cautious 2026 outlook against fresh pipeline momentum and a fast-moving U.S. drug-pricing policy backdrop. As of the latest available quote on Friday, Dec. 19, 2025, Pfizer shares traded

19 December 2025

Dividends · Financial Guidance · Market Trends · NYSE:PFE · Pharmaceuticals · Stock Analysis

Pfizer Stock (PFE) Forecast and News: 2026 Guidance, Drug-Pricing Deals, and Pipeline Catalysts to Watch on Dec. 19, 2025

Pfizer Inc. (NYSE: PFE) stock was essentially flat on Friday, Dec. 19, 2025, trading around $25.04 in midday trading, after a volatile week that blended policy headlines, a reset of near-term financial expectations, and fresh pipeline updates. For investors, the

19 December 2025

Investment Analysis · Market Forecasts · NYSE:PFE · Pfizer News · Pharmaceutical Industry · Stock Market

Pfizer Stock After Hours Today (Dec. 18, 2025): PFE Holds Near $25 — What to Know Before Friday’s Market Open

Pfizer Inc. (NYSE: PFE) ended Thursday’s session essentially flat and stayed steady in after-hours trading, a sign that investors are still digesting the company’s newly issued 2026 outlook while watching a fast-evolving U.S. policy backdrop around drug pricing. As of

19 December 2025

After Hours Trading · Financial News · Investing · NYSE:PFE · Pfizer · Stock Market

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer (NYSE: PFE) stock is trying to regain its footing on Thursday, December 18, 2025, after a volatile mid-December stretch that put the spotlight back on three recurring themes for shareholders: the post-COVID revenue reset, looming loss-of-exclusivity (LOE) headwinds, and

18 December 2025

Drug Pipeline · Healthcare Policy · Market Analysis · Pharmaceutical Stocks · Price Targets

Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts

Pfizer Inc. (NYSE: PFE) stock is trying to steady itself in late December after a volatile stretch driven by one big theme: the post-COVID hangover is still real, and 2026 is shaping up as another “rebuild” year—even as Pfizer spends

18 December 2025

Dividend Stocks · Investment Analysis · NYSE:PFE · Pfizer News · Price Forecasts · Stock Market

Pfizer Stock (PFE) After Hours Today (Dec. 17, 2025): What to Know Before the Market Opens Thursday

Pfizer (NYSE: PFE) finished Wednesday’s session lower and traded only modestly in the after-hours market—an indication that investors are still digesting the company’s newly issued 2026 outlook while weighing fresh pipeline headlines and looming U.S. policy risk around drug pricing.

18 December 2025

After Hours Trading · Financial Analysis · Investing Tips · NYSE:PFE · Pfizer News · Stock Market

Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)

Pfizer Inc. stock (NYSE: PFE) is back in the spotlight on Wednesday, December 17, 2025, as investors digest the drugmaker’s newly issued 2026 outlook, a revised 2025 revenue view, and a longer runway to sustained growth than some shareholders had

17 December 2025

Dividend Outlook · Financial Forecasts · Investment Analysis · NYSE:PFE · Pfizer News · Stock Market

Pfizer Stock (PFE) Slips After 2026 Outlook: Guidance, Analyst Forecasts, Dividend Update, and Key Catalysts to Watch on Dec. 17, 2025

Pfizer Inc. (NYSE: PFE) is back in the spotlight on Wednesday, Dec. 17, 2025, as investors digest a fresh set of financial targets for 2026, updated 2025 revenue expectations, and a growing pile of “what matters next” questions about the

17 December 2025

Dividend News · Financial Forecasts · Investment Analysis · NYSE:PFE · Pharmaceutical Industry · Stock Market